SurModics (SRDX) Tops Q3 EPS by 6c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/7/2026

1. MRVL
2. USO
3. SPY
4. OPCH
5. BBIO
6. NVDA
7. GOOGL
8. CHRW
9. AMD
10. RXO

Go back to SurModics (SRDX) Tops Q3 EPS by 6c

Surmodics Reports Third Quarter Fiscal 2022 Results

July 27, 2022 7:30 AM EDT

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)-- Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced results for its fiscal 2022 third quarter ended June 30, 2022 and updated its financial outlook for its fiscal 2022.

Summary of Third Quarter and Recent Highlights

Revenue of $24.9 million, an increase of 4% year-over-year GAAP EPS of $(0.41), non-GAAP EPS of $(0.34) Fourth consecutive quarter of doubledigit product sales growth yearoveryear

We delivered solid financial results that were in line with... More